Babylon Holdings Limited (BBLNF)

USD 0.0

(0.0%)

EBITDA Summary of Babylon Holdings Limited

Babylon Holdings Limited's latest annual EBITDA in 2022 was -176.72 Million USD , up 962.13% from previous year.
Babylon Holdings Limited's latest quarterly EBITDA in 2023 Q1 was 230.74 Million USD , up 9.42% from previous quarter.
Babylon Holdings Limited reported an annual EBITDA of -62.64 Million USD in 2021, up 47.89% from previous year.
Babylon Holdings Limited reported an annual EBITDA of -161.02 Million USD in 2020, down -1.08% from previous year.
Babylon Holdings Limited reported a quarterly EBITDA of 155.67 Million USD for 2022 Q2, down -6.73% from previous quarter.
Babylon Holdings Limited reported a quarterly EBITDA of N/A for 2022 FY, up 962.13% from previous quarter.

Annual EBITDA Chart of Babylon Holdings Limited (2022 - 2019)

Historical Annual EBITDA of Babylon Holdings Limited (2022 - 2019)

Year	EBITDA	EBITDA Growth
2022	-176.72 Million USD	962.13%
2021	-62.64 Million USD	47.89%
2020	-161.02 Million USD	-1.08%
2019	-159.3 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2023 Q1	230.74 Million USD	9.42%
2022 Q2	155.67 Million USD	-6.73%
2022 FY	- USD	962.13%
2022 Q1	166.9 Million USD	267.12%
2022 Q4	210.88 Million USD	7.65%
2022 Q3	195.89 Million USD	25.84%
2021 Q4	-99.87 Million USD	-86.04%
2021 Q3	-53.68 Million USD	0.0%
2021 FY	- USD	47.89%
2020 FY	- USD	-1.08%
2019 FY	- USD	0.0%

Peer EBITDA Comparison of Babylon Holdings Limited

Name	EBITDA	EBITDA Difference
ETAO International Co., Ltd.	-893.88 Million USD	80.229%
MedAvail Holdings, Inc.	-41.76 Million USD	-323.151%
Micron Solutions, Inc.	-308.4 Thousand USD	-57204.937%
Motus GI Holdings, Inc.	-11.23 Million USD	-1473.722%
ThermoGenesis Holdings, Inc.	-7.74 Million USD	-2183.32%
Titan Medical Inc.	7.51 Million USD	2450.304%
UpHealth, Inc.	-16.89 Million USD	-945.981%